Annual CFI
-$2.58 M
+$85.30 M+97.06%
December 31, 2023
Summary
- As of February 8, 2025, OVID annual cash flow from investing activities is -$2.58 million, with the most recent change of +$85.30 million (+97.06%) on December 31, 2023.
- During the last 3 years, OVID annual CFI has fallen by -$37.23 million (-107.45%).
- OVID annual CFI is now -107.45% below its all-time high of $34.65 million, reached on December 31, 2020.
Performance
OVID Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$292.00 K
-$12.53 M-97.72%
September 30, 2024
Summary
- As of February 8, 2025, OVID quarterly cash flow from investing activities is $292.00 thousand, with the most recent change of -$12.53 million (-97.72%) on September 30, 2024.
- Over the past year, OVID quarterly CFI has increased by +$48.81 million (+100.60%).
- OVID quarterly CFI is now -99.06% below its all-time high of $30.94 million, reached on June 30, 2020.
Performance
OVID Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$15.21 M
+$4.65 M+23.42%
September 30, 2024
Summary
- As of February 8, 2025, OVID TTM cash flow from investing activities is -$15.21 million, with the most recent change of +$4.65 million (+23.42%) on September 30, 2024.
- Over the past year, OVID TTM CFI has dropped by -$12.63 million (-489.54%).
- OVID TTM CFI is now -134.45% below its all-time high of $44.17 million, reached on June 30, 2023.
Performance
OVID TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
OVID Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +97.1% | +100.6% | -489.5% |
| 3 y3 years | -107.5% | +100.6% | -489.5% |
| 5 y5 years | +51.9% | +100.6% | -489.5% |
OVID Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -41.7% | +97.1% | -99.0% | +100.4% | -134.4% | +82.7% |
| 5 y | 5-year | -107.5% | +97.1% | -99.1% | +100.4% | -134.4% | +82.7% |
| alltime | all time | -107.5% | +97.1% | -99.1% | +100.4% | -134.4% | +82.7% |
Ovid Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $292.00 K(-97.7%) | -$15.21 M(-23.4%) |
| Jun 2024 | - | $12.82 M(-36.5%) | -$19.87 M(+57.4%) |
| Mar 2024 | - | $20.19 M(-141.6%) | -$12.62 M(+389.1%) |
| Dec 2023 | -$2.58 M(-97.1%) | -$48.52 M(+1012.7%) | -$2.58 M(-106.2%) |
| Sep 2023 | - | -$4.36 M(-121.7%) | $41.77 M(-5.4%) |
| Jun 2023 | - | $20.07 M(-33.6%) | $44.17 M(-178.1%) |
| Mar 2023 | - | $30.23 M(-825.0%) | -$56.58 M(-35.6%) |
| Dec 2022 | -$87.88 M(+4725.0%) | -$4.17 M(+112.7%) | -$87.88 M(+4.8%) |
| Sep 2022 | - | -$1.96 M(-97.6%) | -$83.88 M(+2.3%) |
| Jun 2022 | - | -$80.68 M(+7396.5%) | -$81.98 M(+2740.5%) |
| Mar 2022 | - | -$1.08 M(+564.3%) | -$2.89 M(+58.5%) |
| Dec 2021 | -$1.82 M(-105.3%) | -$162.00 K(+153.1%) | -$1.82 M(+4.1%) |
| Sep 2021 | - | -$64.00 K(-96.0%) | -$1.75 M(+1.5%) |
| Jun 2021 | - | -$1.58 M(>+9900.0%) | -$1.72 M(-105.6%) |
| Mar 2021 | - | -$11.50 K(-87.3%) | $30.80 M(-11.1%) |
| Dec 2020 | $34.65 M | -$90.50 K(+136.3%) | $34.65 M(<-9900.0%) |
| Sep 2020 | - | -$38.30 K(-100.1%) | -$270.20 K(+7.9%) |
| Jun 2020 | - | $30.94 M(+706.6%) | -$250.50 K(-99.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | $3.84 M(-111.0%) | -$26.20 M(-12.8%) |
| Dec 2019 | -$30.04 M(+460.1%) | -$35.01 M(>+9900.0%) | -$30.04 M(-237.1%) |
| Sep 2019 | - | -$18.60 K(-100.4%) | $21.91 M(-45.0%) |
| Jun 2019 | - | $5.00 M(<-9900.0%) | $39.84 M(+0.4%) |
| Mar 2019 | - | -$9000.00(-100.1%) | $39.70 M(-840.1%) |
| Dec 2018 | -$5.36 M(>+9900.0%) | $16.94 M(-5.4%) | -$5.36 M(-75.9%) |
| Sep 2018 | - | $17.91 M(+269.0%) | -$22.24 M(-44.6%) |
| Jun 2018 | - | $4.85 M(-110.8%) | -$40.18 M(-10.8%) |
| Mar 2018 | - | -$45.07 M(<-9900.0%) | -$45.07 M(>+9900.0%) |
| Dec 2017 | -$47.40 K(-74.9%) | $61.70 K(-343.9%) | -$47.40 K(-76.0%) |
| Sep 2017 | - | -$25.30 K(-18.9%) | -$197.20 K(-16.9%) |
| Jun 2017 | - | -$31.20 K(-40.7%) | -$237.30 K(+11.2%) |
| Mar 2017 | - | -$52.60 K(-40.3%) | -$213.40 K(+12.9%) |
| Dec 2016 | -$189.00 K(+235.7%) | -$88.10 K(+34.7%) | -$189.00 K(+87.3%) |
| Sep 2016 | - | -$65.40 K(+795.9%) | -$100.90 K(+184.2%) |
| Jun 2016 | - | -$7300.00(-74.1%) | -$35.50 K(+25.9%) |
| Mar 2016 | - | -$28.20 K | -$28.20 K |
| Dec 2015 | -$56.30 K | - | - |
FAQ
- What is Ovid Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Ovid Therapeutics?
- What is Ovid Therapeutics annual CFI year-on-year change?
- What is Ovid Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Ovid Therapeutics?
- What is Ovid Therapeutics quarterly CFI year-on-year change?
- What is Ovid Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Ovid Therapeutics?
- What is Ovid Therapeutics TTM CFI year-on-year change?
What is Ovid Therapeutics annual cash flow from investing activities?
The current annual CFI of OVID is -$2.58 M
What is the all time high annual CFI for Ovid Therapeutics?
Ovid Therapeutics all-time high annual cash flow from investing activities is $34.65 M
What is Ovid Therapeutics annual CFI year-on-year change?
Over the past year, OVID annual cash flow from investing activities has changed by +$85.30 M (+97.06%)
What is Ovid Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of OVID is $292.00 K
What is the all time high quarterly CFI for Ovid Therapeutics?
Ovid Therapeutics all-time high quarterly cash flow from investing activities is $30.94 M
What is Ovid Therapeutics quarterly CFI year-on-year change?
Over the past year, OVID quarterly cash flow from investing activities has changed by +$48.81 M (+100.60%)
What is Ovid Therapeutics TTM cash flow from investing activities?
The current TTM CFI of OVID is -$15.21 M
What is the all time high TTM CFI for Ovid Therapeutics?
Ovid Therapeutics all-time high TTM cash flow from investing activities is $44.17 M
What is Ovid Therapeutics TTM CFI year-on-year change?
Over the past year, OVID TTM cash flow from investing activities has changed by -$12.63 M (-489.54%)